MEDANTA — Global Health Income Statement
0.000.00%
Last trade - 00:00- IN₹388.60bn
- IN₹386.43bn
- IN₹26.94bn
Annual income statement for Global Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 15,004 | 14,467 | 21,666 | 26,942 |
| Cost of Revenue | ||||
| Gross Profit | 11,756 | 10,982 | 16,237 | 20,690 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 14,260 | 13,757 | 18,440 | 22,156 |
| Operating Profit | 744 | 711 | 3,226 | 4,787 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 639 | 325 | 2,806 | 4,493 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 363 | 288 | 1,962 | 3,261 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | 363 | 288 | 1,962 | 3,261 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 363 | 288 | 1,962 | 3,261 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 1.36 | 1.06 | 7.25 | 12.6 |
| Dividends per Share |